Published in J Neurochem on October 01, 1986
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem (1994) 3.14
Species and type phages of lactococcal bacteriophages. Intervirology (1991) 2.55
Genome comparison of Lactococcus strains by pulsed-field gel electrophoresis. FEMS Microbiol Lett (1989) 2.36
Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res (1998) 2.35
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
Innovative materials processing strategies: a biomimetic approach. Science (1992) 1.72
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia (2002) 1.55
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
Physical and genetic map of the chromosome of Lactococcus lactis subsp. lactis IL1403. J Bacteriol (1992) 1.43
An X Window system for statlab results reporting. Proc Annu Symp Comput Appl Med Care (1993) 1.43
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther (1998) 1.36
New tools for the physical and genetic mapping of Lactococcus strains. Gene (1992) 1.31
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate. J Biol Chem (1999) 1.26
Taxonomic differentiation of 101 lactococcal bacteriophages and characterization of bacteriophages with unusually large genomes. Appl Environ Microbiol (1990) 1.24
HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther (2007) 1.22
Biomineralization and eggshells: cell-mediated acellular compartments of mineralized extracellular matrix. Int Rev Cytol (1993) 1.22
Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol (1995) 1.22
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Regulation of acetylcholine release from neuroblastoma x glioma hybrid cells. Proc Natl Acad Sci U S A (1978) 1.19
Molecular characterization and comparison of 38 virulent and temperate bacteriophages of Streptococcus lactis. J Gen Microbiol (1987) 1.15
Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A (1996) 1.12
Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol (1989) 1.11
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther (1992) 1.11
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther (1998) 1.08
Differential gene-expression analysis defines a molecular pattern related to olive pollen allergy. J Biol Regul Homeost Agents (2013) 1.07
Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther (1997) 1.06
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol (1996) 1.06
[Ischemic cardiopathy in primary care. A descriptive study]. Aten Primaria (1990) 1.06
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia (2007) 1.05
New form of familial Parkinson-dementia syndrome: clinical and pathologic findings. Neurology (1983) 1.04
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J (2003) 1.04
Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab (2006) 1.01
Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl (1994) 0.98
Factitial oral lesions in an autistic paediatric patient. Int J Paediatr Dent (2003) 0.98
Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell Mol Neurobiol (1991) 0.97
S100 is preferentially distributed in myelin-forming Schwann cells. J Neurocytol (1990) 0.97
Engineering herpes simplex virus vectors for CNS applications. Exp Neurol (1999) 0.97
Isolation of specialized transducing bacteriophages carrying the structural genes of the hexuronate system in Escherichia coli K-12: exu region. J Bacteriol (1978) 0.96
Molecular taxonomy of Lactobacillus phages. Biochimie (1988) 0.96
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol (2009) 0.96
HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol (2001) 0.95
A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther (2009) 0.95
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol (1999) 0.95
Intermolecular interactions in collagen self-assembly as revealed by Fourier transform infrared spectroscopy. Science (1983) 0.94
Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J Clin Microbiol (1987) 0.93
Gene therapy progress and prospects: Parkinson's disease. Gene Ther (2003) 0.93
Cloning, expression and sequence analysis of an endolysin-encoding gene of Lactobacillus bulgaricus bacteriophage mv1. Gene (1990) 0.93
Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol (1990) 0.92
Cytochemical localization of Ca2+-ATPase activity in peripheral nerve. Brain Res (1988) 0.92
Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol (1992) 0.92
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol (2001) 0.92
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci U S A (1999) 0.92
Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J Neurochem (1991) 0.91
The avian eggshell extracellular matrix as a model for biomineralization. Connect Tissue Res (1996) 0.91
Characterization of Lactococcus lactis phage antigens. Appl Environ Microbiol (1992) 0.91
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways. Eur Respir J (2010) 0.90
Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc (1999) 0.89
MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol (1997) 0.89
Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res (1991) 0.88
Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. Clin Chim Acta (2001) 0.88
Serum cholesterol levels in adenomatous polyps and cancer of the colon. A case-control study. JAMA (1986) 0.87
Myocardial rhabdomyosarcoma in multiple neurofibromatosis. Neurology (1981) 0.87
Changes in intra-axonal calcium distribution following nerve crush. J Neurobiol (1986) 0.86
Cerebral atrophy in young cannabis smokers. Lancet (1972) 0.86
Retinoids induce MMP-9 expression through RARalpha during mammary gland remodeling. Am J Physiol Endocrinol Metab (2006) 0.86
Cancer overview. Cancer Res (1979) 0.85
Distribution of albumin-like immunoreactivity in rat sciatic nerve after nerve crush injury. J Neuropathol Exp Neurol (1988) 0.85
Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo. Science (1980) 0.84
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther (2011) 0.83
Effectiveness of oral N -acetylcysteine in a rat experimental model of asthma. Pharmacol Res (2002) 0.83
Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (2001) 0.83
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J Virol (1996) 0.83
Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study. Aliment Pharmacol Ther (2009) 0.83
Ultrastructural distribution of Ca++ within neurons. An oxalate pyroantimonate study. Histochemistry (1987) 0.83